W. Jelkmann

发表

Proinflammatory cytokines lowering erythropoietin production.

W. Jelkmann, Wolfgang Jelkmann, W. Jelkmann, 1998, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Pericellular PO2 and O2 consumption in monolayer cell cultures.

W. Jelkmann, E. Metzen, J. Fandrey, 1995, Respiration physiology.

Interleukin-1β and Tumor Necrosis Factor- Stimulate DNA Binding of Hypoxia-Inducible Factor-1

W. Jelkmann, E. Metzen, J. Fandrey, 1999 .

Role of hydrogen peroxide in hypoxia-induced erythropoietin production.

W. Jelkmann, S. Frede, J. Fandrey, 1994, The Biochemical journal.

Cobalt chloride and desferrioxamine antagonize the inhibition of erythropoietin production by reactive oxygen species.

W. Jelkmann, S. Frede, J. Fandrey, 1997, Kidney international.

Activity in fetal bovine serum that stimulates erythroid colony formation in fetal mouse livers is insulinlike growth factor I.

W. Jelkmann, A. Kurtz, C. Bauer, 1985, The Journal of clinical investigation.

Pitfalls in the measurement of circulating vascular endothelial growth factor.

W. Jelkmann, Wolfgang Jelkmann, Wolfgang Jelkmann, 2001, Clinical chemistry.

Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys.

W. Jelkmann, M. Wolff, J. Fandrey, 1992, Life sciences.

Hypoxia and interleukin-1beta stimulate vascular endothelial growth factor production in human proximal tubular cells.

W. Jelkmann, E. Metzen, J. Fandrey, 2000, Kidney international.

Interleukin-1β and Tumor Necrosis Factor- Stimulate DNA Binding of Hypoxia-Inducible Factor-1

W. Jelkmann, E. Metzen, J. Fandrey, 1999 .

Erythropoietin gene expression is suppressed after lipopolysaccharide or interleukin-1 beta injections in rats.

W. Jelkmann, S. Frede, J. Fandrey, 1997, The American journal of physiology.

Effects of erythropoietin on brain function.

W. Jelkmann, W. Jelkmann, 2005, Current pharmaceutical biotechnology.

Chronic inborn erythrocytosis leads to cardiac dysfunction and premature death in mice overexpressing erythropoietin.

M. Gassmann, W. Jelkmann, D. Katschinski, 2001, Blood.

Perioperative use of recombinant human erythropoietin in patients refusing blood transfusions. Pathophysiological considerations based on 5 cases

W. Jelkmann, J. Fandrey, A. Hirner, 1997, European journal of haematology.

Decreased erythropoietin response in Plasmodium falciparum malaria‐associated anaemia

W. Jelkmann, J. Fandrey, A. Saeed, 1997, European journal of haematology.

Microelectrode measurements of pericellular PO2 in erythropoietin-producing human hepatoma cell cultures.

W. Jelkmann, J. Fandrey, W Jelkmann, 1993, The American journal of physiology.

Isolated serum-free perfused rat kidneys release immunoreactive erythropoietin in response to hypoxia.

W. Jelkmann, H. Pagel, C. Weiss, 1991, Endocrinology.

Biology of erythropoietin.

W. Jelkmann, Wolfgang Jelkmann, T. Hellwig-Bürgel, 1994, The Clinical investigator.

Distinct signaling pathways mediate phorbol-ester-induced and cytokine-induced inhibition of erythropoietin gene expression.

J. Pfeilschifter, W. Jelkmann, A. Huwiler, 1994, European journal of biochemistry.

Expression of the thrombopoietin gene in human fetal and neonatal tissues.

W. Jelkmann, J. Fandrey, C. Dame, 1999, Blood.

The role of the liver in the production of thrombopoietin compared with erythropoietin.

W. Jelkmann, Wolfgang Jelkmann, W. Jelkmann, 2001, European journal of gastroenterology & hepatology.

Photometric characteristics of haem proteins in erythropoietin-producing hepatoma cells (HepG2).

J. Hancock, W. Jelkmann, H. Acker, 1993, The Biochemical journal.

Erythropoiesis stimulating agents and techniques: a challenge for doping analysts.

W. Jelkmann, Wolfgang Jelkmann, W. Jelkmann, 2009, Current medicinal chemistry.

Erythropoietin in the control of red cell production.

W. Jelkmann, E. Metzen, Wolfgang Jelkmann, 1996, Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft.

Tumor necrosis factor-alpha and TNF-beta inhibit clonogenicity of mobilized human hematopoietic progenitors.

W. Jelkmann, P. Schlenke, V. Skobin, 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Dexamethasone impairs hypoxia-inducible factor-1 function.

W. Jelkmann, D. Stiehl, T. Hellwig-Bürgel, 2008, Biochemical and biophysical research communications.

Interleukin-6 increases thrombopoietin production in human hepatoma cells HepG2 and Hep3B.

W. Jelkmann, E. Wolber, W. Jelkmann, 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Serum thrombopoietin and interleukin 6 concentrations in tumour patients and response to chemotherapy‐induced thrombocytopenia

W. Jelkmann, D. Katschinski, G. Wiedemann, 1997, European journal of haematology.

Tumor necrosis factor p55 receptor (TNF-RI) mediates the in vitro inhibition of hepatic erythropoietin production.

W. Jelkmann, T. Hellwig-Buergel, Wolfgang Jelkmann, 1999, Experimental hematology.

Tumor Necrosis Factor-α Production by Human Hepatoma Cell Lines Is Resistant to Drugs That Are Inhibitory to Macrophages

W. Jelkmann, J. Fandrey, M. Wördemann, 1998 .